EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
2.4.2.31 | heparin | - |
Homo sapiens | |
2.4.2.31 | heparin | - |
Bos taurus | |
2.4.2.31 | NAD+ | excess | Homo sapiens | |
2.4.2.31 | NAD+ | excess | Bos taurus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.2.31 | FGF-2 + NAD+ | Homo sapiens | ADP-ribosylation of FGF-2 may provide an additional level of control of FGF-2 activity | ? | - |
? | |
2.4.2.31 | FGF-2 + NAD+ | Bos taurus | ADP-ribosylation of FGF-2 may provide an additional level of control of FGF-2 activity | ? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.2.31 | Bos taurus | - |
- |
- |
2.4.2.31 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.4.2.31 | aortic endothelium | aortic arch endothelium | Bos taurus | - |
2.4.2.31 | hepatoma cell | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.2.31 | basic fibroblast growth factor FGF-2 + NAD+ | - |
Homo sapiens | nicotinamide + ? | - |
? | |
2.4.2.31 | basic fibroblast growth factor FGF-2 + NAD+ | - |
Bos taurus | nicotinamide + ? | - |
? | |
2.4.2.31 | FGF-2 + NAD+ | ADP-ribosylation of FGF-2 may provide an additional level of control of FGF-2 activity | Homo sapiens | ? | - |
? | |
2.4.2.31 | FGF-2 + NAD+ | ADP-ribosylation of FGF-2 may provide an additional level of control of FGF-2 activity | Bos taurus | ? | - |
? |